Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Klimant
Blood Type, Hormone Receptor Status, HER2/neu Status, and Survival in Breast Cancer: A Retrospective Study Exploring Relationships in a Phenotypically Well-Defined Cohort
Clinical Medicine and Research
Medicine
Home Care
Community
Related publications
Effects of Marital Status on Breast Cancer Survival by Age, Race, and Hormone Receptor Status: A Population‐based Study
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Exploring Prognostic Factors for HER2-positive Metastatic Breast Cancer: A Retrospective Cohort Study in a Major Swiss Hospital
Swiss Medical Weekly
Medicine
Neoadjuvant Treatment of HER2-positive Breast Cancer: Should Therapy Differ Based on Hormone Receptor Status?
Therapeutic Advances in Medical Oncology
Oncology
Estrogen Receptor and HER2/neu Status Affect Epigenetic Differences of Tumor-Related Genes in Primary Breast Tumors
Breast Cancer Research
Cancer Research
Oncology
ID3014 Evaluation of HER2 Status in Breast Cancer: Current Status and Future Directions
Biomedical Research and Therapy
Biochemistry
Medicine
Genetics
Molecular Biology
Oestrogen Receptor Status and Survival in Women With BRCA2-associated Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
The Association of Soy Food Consumption With the Risk of Subtype of Breast Cancers Defined by Hormone Receptor and HER2 Status
International Journal of Cancer
Cancer Research
Oncology
Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study
European Journal of Breast Health
Carotenoid Intakes and Risk of Breast Cancer Defined by Estrogen Receptor and Progesterone Receptor Status: A Pooled Analysis of 18 Prospective Cohort Studies
